Aurobindo Pharma
The pharma company reported a 32.4% year-on-year decline in consolidated profit at Rs 520.4 crore for the quarter ended June 30, 2022, impacted by lower other income and operating income. Revenue surged by 9.4% to Rs 6,236 crore compared to Rs 5,702 crore in the same quarter of the previous financial year. US formulations business increased 10.8%, but Europe formulation business fell 2.2% mainly due to euro currency depreciation.
Also Read | Trade Setup: Top 15 things to know before market opens on August 12, 2022
Oil India
The country’s second-largest state explorer reported a three-fold increase in net profit at Rs 1,555.46 crore for the April-June 2022 quarter compared to Rs 507.94 crore in the year-ago period. Revenue almost doubled to Rs 6,029.86 crore in the first quarter of fiscal 2022. The earnings were aided by a 4% rise in crude oil production at 0.78 million tonnes and an 8% rise in gas output at 771 million standard cubic meters.
Also Read | Stocks to watch on Friday, August 12, 2022
Bata India
The company reported a 71.82% increase in consolidated net profit at Rs 119.37 crore for the first quarter of fiscal 2023 as the shoemaker achieved the “highest ever quarterly sales”. The company had posted a net profit of Rs 69.47 crore in the April-June quarter of fiscal 2021-22. Its revenue from operations during the reported quarter stood at Rs 943.01 crore, up over three-fold from Rs 267.04 crore in the year-ago period. This was supported by a continuous increase in portfolio and marketing investments.
Also Read | Coal India shares rise after robust Q1 earnings
Balaji Amines
Subsidiary Balaji Speciality Chemicals has filed a draft red herring prospectus with the Securities and Exchange Board of India (SEBI) for fundraising through an initial public offering (IPO). The offer consists of a fresh issue of equity shares worth Rs 250 crore and an offer for sale of 2.6 crore shares by certain existing and eligible shareholders of Balaji Speciality Chemicals. Balaji Amines will not be participating in the proposed offer.
Also Read | ED launches probe into crypto exchanges for money laundering of Rs 1,000 crore
Apollo Hospitals
The Healthcare services provider reported a 35.3% year-on-year decline in consolidated profit at Rs 323.8 crore for the April-June quarter of fiscal 2023 on a high base. Consolidated revenue from operations during the reported quarter stood at Rs 3,795.6 crore as against Rs 3,760.21 crore in the year-ago period.
Also Read | ICICI Bank share hits record high as net profit rises 49% YoY in Q1FY23
Sterling and Wilson Renewable Energy
The promoter Shapoorji Pallonji and Company is going to sell up to 23.7 lakh shares or 1.25% stake through an offer for sale (OFS) on August 12 and August 16. The floor price of the offer will be Rs 270 per share.
Also Read | Asian shares track Wall Street gains on cooling inflation
Aster DM Healthcare
The company posted a 35% year-on-year increase in consolidated profit at Rs 79.77 crore in the first quarter (April-June) of fiscal 2023, on account of operating performance, other income, and top line. Revenue increased by 12% to Rs 2,662 crore compared to the year-ago period.
Also Read | Indian companies bought Russian coal using yuan, euro instead of US dollar
Gujarat Ambuja Exports
The company posted a 0.7% year-on-year growth in consolidated profit at Rs 114.60 crore for the quarter ended June 30, 2022, impacted by higher input costs and a fall in operating income. Consolidated revenue increased by 24.2% to Rs 1,272.86 crore compared to the year-ago period.
Also Read | Is it better to invest in real estate during surging inflation?
KSB
The company reported a 74.3% year-on-year growth in consolidated net profit at Rs 47.40 crore in the April-June quarter of fiscal 2022, driven by the higher top line, operating income, and other income. Revenue surged by 48% to Rs 448.40 crore in the reported quarter.
